(RTTNews) – Royal Philips (PHG), and Elekta said that they have signed agreements to advance comprehensive and personalized cancer care through precision oncology solutions.
In the partnership, the companies will leverage their capabilities to pursue integrated vendor-agnostic solutions, enhancing interoperability between the two parties’ systems and software in order to drive precision in oncology.
Oncology care is transforming, driven by an increasingly precise diagnosis of each tumor, and a continuously expanding range of therapy options. Healthcare providers require integrated solutions throughout the entire cancer care pathway, from diagnosis to treatment and follow-up.
Recommended articles
IFS completes the acquisition of global Enterprise Service Management provider Axios SystemsLONDON and EDINBURGH, Scotland, June 10, 2021 /PRNewswire/ -- IFS, the global cloud enterprise applications company, announces that it has concluded the acquisition of Axios Systems.The transaction, w...(read more)
CleanEquity® Monaco 2021 – Registration and CollaborationLONDON, June 10, 2021 /PRNewswire/ -- CleanEquity® was founded in 2007 by His Serene Highness Prince Albert II of Monaco & Mungo Park, Chair of Innovator Capital. The conference, aimed at accelerating...(read more)
Three 'explosive-laden drones' used in Baghdad airport attack: ArmyBAGHDAD (AFP) - The latest attack on Baghdad airport, where US soldiers are deployed, was carried out with three "explosive-laden drones", the army said in a statement Thursday (June 10). It said one...(read more)
Moderna Files For EUA For Its COVID-19 Vaccine In Adolescents In US – Quick Facts(RTTNews) - Biotechnology company Moderna, Inc., (MRNA) announced Thursday that it has requested an emergency use authorization (EUA) for its COVID-19 vaccine in adolescents with the U.S. Food and Dru...(read more)